Navigation Links
NIH Stem Cell Guidelines Ethically Irresponsible, Scientifically Unworthy, Useless to Patients, Says Family Research Council

WASHINGTON, July 7 /PRNewswire-USNewswire/ -- Today, Family Research Council President Tony Perkins responded to the National Institutes of Health (NIH) guidelines implementing President Obama's executive order for federal funding of human embryonic stem cell research (ESCR). President Obama's order and the NIH guidelines remove life-protecting limits on federal funding of embryonic stem cell research.


"Embryonic stem cell research requires dissecting and commoditizing the youngest, most vulnerable humans," said Family Research Council President Tony Perkins. "The new guidelines demanded by the President promote poor science, reflect bad health care policy, and do nothing to fund treatments with adult stem cells that are providing documented benefits for suffering patients. The guidelines implement a plan that will force taxpayers to foot the bill for research that involves human destruction, not healing.

"The NIH guidelines create an incentive to create and destroy so-called 'excess' embryos, pasting a veneer of 'ethics' on unethical experiments. They remove limits on taxpayer funding of experiments that require embryo destruction, and open the door to future abuses. NIH clearly believes the President's order allows them to fund other forms of unethical research at any point in the future.

"The guidelines purport to have tight informed consent requirements, but don't even require the IVF doctor and the stem cell researcher to be separate persons, opening a gaping loophole for researchers to increase embryo production for their own purposes," added Perkins.

"Acting NIH director Raynard Kington apparently noted that 30,000 of the 49,000 comments received were against any federal funding of human embryonic stem cell research, but these comments (including FRC's extensive comments were ignored.

"Instead of funding more life-destroying experiments, federal funding should go toward life-saving treatments and clinical trials using adult stem cells, which are on the cutting edge of treating patients for diabetes, spinal cord injury, heart disease, multiple sclerosis, and other diseases," concluded Perkins.

SOURCE Family Research Council
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Updates Prescription Guidelines for Blood Thinner
2. New Asthma Guidelines Stress Disease Control
3. Study finds primary care depression treatment often does not follow quality guidelines
4. New lung cancer guidelines oppose general CT screening
5. New Lung Cancer Guidelines Oppose General CT Screening
6. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
7. Long-awaited international ethical guidelines for biobank researchers
8. Experts Publish New Lung Disease Guidelines
9. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
10. New guidelines set to improve standard of cows milk allergy care
11. GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology
Post Your Comments:
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
Breaking Medicine Technology: